Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,338 | -10,012 | -9,879 | -10,628 | -9,891 |
| Depreciation Amortization | 91 | 253 | 16 | 13 | 11 |
| Other Working Capital | -295 | 285 | 1,943 | 2,358 | 1,295 |
| Other Operating Activity | 17,207 | 2,678 | 3,318 | 724 | 1,659 |
| Operating Cash Flow | $-11,335 | $-6,796 | $-4,602 | $-7,533 | $-6,926 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -4 | N/A | -1 | -48 |
| Net Acquisitions | -120 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -294 |
| Investing Cash Flow | $-123 | $-4 | $N/A | $-1 | $-342 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 163 | 1,880 | N/A | N/A | 961 |
| Common Stock Issued | 75,460 | N/A | 11,426 | 1,542 | 614 |
| Other Financing Activity | -277 | -200 | -1,335 | 0 | 0 |
| Financing Cash Flow | $75,346 | $1,680 | $10,091 | $1,542 | $1,575 |
| Exchange Rate Effect | 1,736 | 16 | -249 | 254 | -1,633 |
| Beginning Cash Position | 200 | 5,304 | 64 | 5,802 | 13,128 |
| End Cash Position | 65,824 | 200 | 5,304 | 64 | 5,802 |
| Net Cash Flow | $65,624 | $-5,104 | $5,240 | $-5,738 | $-7,326 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,335 | -6,796 | -4,602 | -7,533 | -6,926 |
| Capital Expenditure | -3 | -4 | N/A | -1 | -48 |
| Free Cash Flow | -11,338 | -6,800 | -4,602 | -7,534 | -6,974 |